-
1
-
-
0027480960
-
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
-
The Huntington's Disease Collaborative Research Group.
-
The Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
-
(1993)
Cell
, vol.72
, pp. 971-983
-
-
-
2
-
-
0027176364
-
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
-
Andrew, S. E., Goldberg, Y. P., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M. A., et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4, 398-403.
-
(1993)
Nat. Genet.
, vol.4
, pp. 398-403
-
-
Andrew, S.E.1
Goldberg, Y.P.2
Kremer, B.3
Telenius, H.4
Theilmann, J.5
Adam, S.6
Starr, E.7
Squitieri, F.8
Lin, B.9
Kalchman, M.A.10
-
3
-
-
3242659833
-
Onset and rate of striatal atrophy in preclinical Huntington disease
-
Aylward, E. H., Sparks, B. F., Field, K. M., Yallapragada, V, Shpritz, B. D., Rosenblatt, A., Brandt, J., Gourley, L. M., Liang, K., Zhou, H., Margolis, R. L., and Ross, C. A. (2004) Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology. 63, 66-72.
-
(2004)
Neurology.
, vol.63
, pp. 66-72
-
-
Aylward, E.H.1
Sparks, B.F.2
Field, K.M.3
Yallapragada, V.4
Shpritz, B.D.5
Rosenblatt, A.6
Brandt, J.7
Gourley, L.M.8
Liang, K.9
Zhou, H.10
Margolis, R.L.11
Ross, C.A.12
-
4
-
-
0034305621
-
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
-
Eng, L. F., Ghirnikar, R. S., and Lee, Y. L. (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25, 1439-1451.
-
(2000)
Neurochem. Res.
, vol.25
, pp. 1439-1451
-
-
Eng, L.F.1
Ghirnikar, R.S.2
Lee, Y.L.3
-
5
-
-
34548331451
-
Is the ubiquitin-proteasome system impaired in Huntington's disease?
-
Ortega, Z., Díaz-Hernández, M., and Lucas, J. J. (2007) Is the ubiquitin-proteasome system impaired in Huntington's disease? Cell Mol. Life Sci. 64, 2245-2257.
-
(2007)
Cell Mol. Life Sci.
, vol.64
, pp. 2245-2257
-
-
Ortega, Z.1
Díaz-Hernández, M.2
Lucas, J.J.3
-
6
-
-
0036566675
-
Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin
-
Wyttenbach, A., Sauvageot, O., Carmichael, J., Diaz-Latoud, C., Arrigo, A. P., and Rubinsztein, D. C. (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11, 1137-1151.
-
(2002)
Hum. Mol. Genet.
, vol.11
, pp. 1137-1151
-
-
Wyttenbach, A.1
Sauvageot, O.2
Carmichael, J.3
Diaz-Latoud, C.4
Arrigo, A.P.5
Rubinsztein, D.C.6
-
7
-
-
0033080367
-
Glutamine repeats and neurodegenerative diseases: molecular aspects
-
Perutz, M. F. (1999) Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24, 58-63.
-
(1999)
Trends Biochem. Sci.
, vol.24
, pp. 58-63
-
-
Perutz, M.F.1
-
8
-
-
77951988103
-
Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo
-
Legleiter, J., Mitchell, E., Lotz, G. P., Sapp, E., Ng, C., DiFiglia, M., Thompson, L. M., and Muchowski, P. J. (2010) Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo. J. Biol. Chem. 285, 14777-14790.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 14777-14790
-
-
Legleiter, J.1
Mitchell, E.2
Lotz, G.P.3
Sapp, E.4
Ng, C.5
DiFiglia, M.6
Thompson, L.M.7
Muchowski, P.J.8
-
9
-
-
78650811716
-
Formation and toxicity of soluble polyglutamine oligomers in living cells
-
Lajoie, P. and Snapp, E. L. (2010) Formation and toxicity of soluble polyglutamine oligomers in living cells. PLoS One. 5, e15245.
-
(2010)
PLoS One.
, vol.5
-
-
Lajoie, P.1
Snapp, E.L.2
-
10
-
-
79952585486
-
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage
-
Shirendeb, U., Reddy, A. P., Manczak, M., Calkins, M. J., Mao, P., Tagle, D. A., and Reddy, P. H. (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet. 20, 1438-1455.
-
(2011)
Hum. Mol. Genet.
, vol.20
, pp. 1438-1455
-
-
Shirendeb, U.1
Reddy, A.P.2
Manczak, M.3
Calkins, M.J.4
Mao, P.5
Tagle, D.A.6
Reddy, P.H.7
-
11
-
-
79955970952
-
Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein
-
Fox, J., Connor, T., Stiles, M., Kama, J., Lu, Z., Dorsey, K., Liebermann, G., Sapp, E., Cherny, R.A., Banks, M., Volitakis, I., DiFiglia, M., Berezovska, O., Bush, A. I., and Hersc, S. M. (2011) Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein. J. Biol. Chem. 286, 18320-18330.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 18320-18330
-
-
Fox, J.1
Connor, T.2
Stiles, M.3
Kama, J.4
Lu, Z.5
Dorsey, K.6
Liebermann, G.7
Sapp, E.8
Cherny, R.A.9
Banks, M.10
Volitakis, I.11
DiFiglia, M.12
Berezovska, O.13
Bush, A.I.14
Hersc, S.M.15
-
12
-
-
0032971311
-
Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin
-
Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R., and Raymondm, L. A. (1999) Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. Neurochem. 72, 1890-1898.
-
(1999)
J. Neurochem.
, vol.72
, pp. 1890-1898
-
-
Chen, N.1
Luo, T.2
Wellington, C.3
Metzler, M.4
McCutcheon, K.5
Hayden, M.R.6
Raymondm, L.A.7
-
13
-
-
0021883670
-
Regional mitochondrial respiratory activity in Huntington's disease brain
-
Brennan, W. A. Jr., Bird, E. D., and Aprille, J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
-
(1985)
J. Neurochem.
, vol.44
, pp. 1948-1950
-
-
Brennan Jr, W.A.1
Bird, E.D.2
Aprille, J.R.3
-
14
-
-
0028936986
-
Bioenergetic and oxidative stress in neurodegenerative diseases
-
Bowling, A. C. and Beal, M. F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171.
-
(1995)
Life Sci.
, vol.56
, pp. 1151-1171
-
-
Bowling, A.C.1
Beal, M.F.2
-
15
-
-
0028856571
-
Trial of d-alpha-tocopherol in Huntington's disease
-
Peyser, C. E., Folstein, M., Chase, G. A., Starkstein, S., Brandt, J., Cockrell, J. R., Bylsma, F., Coyle, J. T., McHugh, P. R., and Folstein, S. E. (1995) Trial of d-alpha-tocopherol in Huntington's disease. Am. J. Psychiatry 152, 1771-1775.
-
(1995)
Am. J. Psychiatry
, vol.152
, pp. 1771-1775
-
-
Peyser, C.E.1
Folstein, M.2
Chase, G.A.3
Starkstein, S.4
Brandt, J.5
Cockrell, J.R.6
Bylsma, F.7
Coyle, J.T.8
McHugh, P.R.9
Folstein, S.E.10
-
16
-
-
0030919567
-
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia
-
Browne, S. E., Bowling, A. C., MacGarvey, U., Baik, M. J., Berger, S. C., Muqit, M. M., Bird, E. D., and Beal, M. F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
-
(1997)
Ann. Neurol.
, vol.41
, pp. 646-653
-
-
Browne, S.E.1
Bowling, A.C.2
MacGarvey, U.3
Baik, M.J.4
Berger, S.C.5
Muqit, M.M.6
Bird, E.D.7
Beal, M.F.8
-
17
-
-
0032900574
-
Biochemical abnormalities and excitotoxicity in Huntington's disease brain
-
Tabrizi, S. J., Cleeter, M. W., Xuereb, J., Taanman, J. W., Cooper, J. M., and Schapira, A. H. (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain, Ann. Neurol. 45, 25-32.
-
(1999)
Ann. Neurol.
, vol.45
, pp. 25-32
-
-
Tabrizi, S.J.1
Cleeter, M.W.2
Xuereb, J.3
Taanman, J.W.4
Cooper, J.M.5
Schapira, A.H.6
-
18
-
-
33749557821
-
Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III
-
Solans, A., Zambrano, A., Rodríguez, M., and Barrientos, A. (2006) Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III. Hum. Mol. Genet. 15, 3063-3081.
-
(2006)
Hum. Mol. Genet.
, vol.15
, pp. 3063-3081
-
-
Solans, A.1
Zambrano, A.2
Rodríguez, M.3
Barrientos, A.4
-
19
-
-
77952296549
-
Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis
-
Ocampo, A., Zambrano, A., and Barrientos, A. (2010) Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis. Faseb J. 24, 1431-1441.
-
(2010)
Faseb J.
, vol.24
, pp. 1431-1441
-
-
Ocampo, A.1
Zambrano, A.2
Barrientos, A.3
-
20
-
-
79955891292
-
Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation
-
Sorolla, M. A., Nierga, C., Rodríguez-Colman, M. J., Reverter-Branchat, G., Arenas, A., Tamarit, J., Ros, J., and Cabiscol, E. (2011) Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation. Arch. Biochem. Biophys. 510, 27-34.
-
(2011)
Arch. Biochem. Biophys.
, vol.510
, pp. 27-34
-
-
Sorolla, M.A.1
Nierga, C.2
Rodríguez-Colman, M.J.3
Reverter-Branchat, G.4
Arenas, A.5
Tamarit, J.6
Ros, J.7
Cabiscol, E.8
-
21
-
-
0021917344
-
Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyltranspeptidase in post-mortem brain from Huntington's disease and agonal cases
-
Butterworth, J., Yates, C. M., and Reynolds, G. P. (1985) Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyltranspeptidase in post-mortem brain from Huntington's disease and agonal cases. J. Neurol. Sci. 67, 161-171.
-
(1985)
J. Neurol. Sci.
, vol.67
, pp. 161-171
-
-
Butterworth, J.1
Yates, C.M.2
Reynolds, G.P.3
-
22
-
-
48449091060
-
Proteomic and oxidative stress analysis in human brain samples of Huntington disease
-
Sorolla, M. A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J., and Cabiscol, E. (2008) Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic. Biol. Med. 45, 667-678.
-
(2008)
Free Radic. Biol. Med.
, vol.45
, pp. 667-678
-
-
Sorolla, M.A.1
Reverter-Branchat, G.2
Tamarit, J.3
Ferrer, I.4
Ros, J.5
Cabiscol, E.6
-
23
-
-
0035668684
-
Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease
-
Bogdanov, M. B., Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., and Beal, M. F. (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J. Neurochem. 79, 1246-1249.
-
(2001)
J. Neurochem.
, vol.79
, pp. 1246-1249
-
-
Bogdanov, M.B.1
Andreassen, O.A.2
Dedeoglu, A.3
Ferrante, R.J.4
Beal, M.F.5
-
24
-
-
0033596751
-
Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease
-
Montine, T. J., Beal, M. F., Robertson, D., Cudkowicz, M. E., Biaggioni, I., O'Donnell, H., Zackert, W. E., Roberts, L. J., and Morrow, J. D. (1999) Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology 52, 1104-1105.
-
(1999)
Neurology
, vol.52
, pp. 1104-1105
-
-
Montine, T.J.1
Beal, M.F.2
Robertson, D.3
Cudkowicz, M.E.4
Biaggioni, I.5
O'Donnell, H.6
Zackert, W.E.7
Roberts, L.J.8
Morrow, J.D.9
-
25
-
-
0342635463
-
Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease
-
Perez-Severiano, Ríos, C., and Segovia, J. (2000) Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res. 862, 234-237.
-
(2000)
Brain Res.
, vol.862
, pp. 234-237
-
-
Perez-Severiano1
Ríos, C.2
Segovia, J.3
-
26
-
-
57649171133
-
Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants
-
Stack, E. C., Matson, W. R., and Ferrante, R. J. (2008) Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants. Ann. N.Y. Acad. Sci. 1147, 79-92.
-
(2008)
Ann. N.Y. Acad. Sci.
, vol.1147
, pp. 79-92
-
-
Stack, E.C.1
Matson, W.R.2
Ferrante, R.J.3
-
27
-
-
73449089819
-
Nitric oxide in cell survival: a janus molecule
-
Calabrese, V., Cornelius, C., Rizzarelli, E., Owen, J. B., Dinkova-Kostova, A. T., and Butterfield, D. A. (2009) Nitric oxide in cell survival: a janus molecule. Antioxid. Redox Signal. 11, 2717-2739.
-
(2009)
Antioxid. Redox Signal.
, vol.11
, pp. 2717-2739
-
-
Calabrese, V.1
Cornelius, C.2
Rizzarelli, E.3
Owen, J.B.4
Dinkova-Kostova, A.T.5
Butterfield, D.A.6
-
28
-
-
84455173005
-
In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production
-
Hands, S., Sajjad, M. U., Newton, M. J., and Wyttenbach, A. (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J. Biol. Chem. 286, 44512-44520.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 44512-44520
-
-
Hands, S.1
Sajjad, M.U.2
Newton, M.J.3
Wyttenbach, A.4
-
29
-
-
33751080354
-
Huntingtin inclusion bodies are iron-dependent centers of oxidative events
-
Firdaus, W. J., Wyttenbach, A., Giuliano, P., Kretz-Remy, C., Currie, R. W., and Arrigo, A. P. (2006) Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J. 273, 5428-5441.
-
(2006)
FEBS J.
, vol.273
, pp. 5428-5441
-
-
Firdaus, W.J.1
Wyttenbach, A.2
Giuliano, P.3
Kretz-Remy, C.4
Currie, R.W.5
Arrigo, A.P.6
-
30
-
-
0032890824
-
Increased basal ganglia iron levels in Huntington disease
-
Bartzokis, G., Cummings, J., Perlman, S., Hance, D. B., and Mintz, J. (1999) Increased basal ganglia iron levels in Huntington disease. Arch. Neurol. 56, 569-574.
-
(1999)
Arch. Neurol.
, vol.56
, pp. 569-574
-
-
Bartzokis, G.1
Cummings, J.2
Perlman, S.3
Hance, D.B.4
Mintz, J.5
-
31
-
-
34447520021
-
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
-
Simmons, D. A., Casale, M., Alcon, B., Pham, N., Narayan, N., and Lynch, G. (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55, 1074-1084.
-
(2007)
Glia
, vol.55
, pp. 1074-1084
-
-
Simmons, D.A.1
Casale, M.2
Alcon, B.3
Pham, N.4
Narayan, N.5
Lynch, G.6
-
32
-
-
33845768784
-
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
-
Block, M. L., Zecca, L., and Hong, J. S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69.
-
(2007)
Nat. Rev. Neurosci.
, vol.8
, pp. 57-69
-
-
Block, M.L.1
Zecca, L.2
Hong, J.S.3
-
33
-
-
1642308134
-
Neurodegenerative diseases and oxidative stress
-
Barnham, K. J., Masters, C. L., and Bush, A. I. (2004) Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205-214.
-
(2004)
Nat. Rev. Drug Discov.
, vol.3
, pp. 205-214
-
-
Barnham, K.J.1
Masters, C.L.2
Bush, A.I.3
-
34
-
-
0032815680
-
Replicating Huntington's disease phenotype in experimental animals
-
Brouillet, E., Condé, F., Beal, M. F., and Hantraye, P. (1999) Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol. 59, 427-468.
-
(1999)
Prog. Neurobiol.
, vol.59
, pp. 427-468
-
-
Brouillet, E.1
Condé, F.2
Beal, M.F.3
Hantraye, P.4
-
35
-
-
0026584524
-
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
-
Beal, M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
-
(1992)
Ann. Neurol.
, vol.31
, pp. 119-130
-
-
Beal, M.F.1
-
36
-
-
0034737299
-
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
-
Yamamoto, A., Lucas, J. J., and Hen, R. (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell. 101, 57-66.
-
(2000)
Cell.
, vol.101
, pp. 57-66
-
-
Yamamoto, A.1
Lucas, J.J.2
Hen, R.3
-
37
-
-
77954542302
-
Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism
-
Sorolla, M. A., Rodríguez-Colman, M. J., Tamarit, J., Ortega, Z, Lucas, J. J., Ferrer, I., Ros, J., and Cabiscol, E. (2010) Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radic. Biol. Med. 49, 612-621.
-
(2010)
Free Radic. Biol. Med.
, vol.49
, pp. 612-621
-
-
Sorolla, M.A.1
Rodríguez-Colman, M.J.2
Tamarit, J.3
Ortega, Z.4
Lucas, J.J.5
Ferrer, I.6
Ros, J.7
Cabiscol, E.8
-
38
-
-
20444369178
-
Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract
-
Balu, M., Sangeetha, P., Haripriya, D., and Panneerselvam, C. (2005) Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract. Neurosci. Lett. 383, 295-300.
-
(2005)
Neurosci. Lett.
, vol.383
, pp. 295-300
-
-
Balu, M.1
Sangeetha, P.2
Haripriya, D.3
Panneerselvam, C.4
-
39
-
-
0028291974
-
Carbonyl assays for determination of oxidatively modified proteins
-
Levine, R. L., Williams, J. A., Stadtman, E. R., and Shacter, E. (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233, 346-357.
-
(1994)
Methods Enzymol.
, vol.233
, pp. 346-357
-
-
Levine, R.L.1
Williams, J.A.2
Stadtman, E.R.3
Shacter, E.4
-
40
-
-
3843151554
-
Oxidative damage to specific proteins in replicative and chronological-aged Saccharomyces cerevisiae: common targets and prevention by calorie restriction
-
Reverter-Branchat, G., Cabiscol, E., Tamarit, J., and Ros, J. (2004) Oxidative damage to specific proteins in replicative and chronological-aged Saccharomyces cerevisiae: common targets and prevention by calorie restriction. J. Biol. Chem. 279, 31983-31989.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 31983-31989
-
-
Reverter-Branchat, G.1
Cabiscol, E.2
Tamarit, J.3
Ros, J.4
-
41
-
-
41549083260
-
Major targets of iron-induced protein oxidative damage in frataxin-deficient yeasts are magnesium-binding proteins
-
Irazusta, V., Moreno-Cermeño, A., Cabiscol, E., Ros, J., and Tamarit, J. (2008) Major targets of iron-induced protein oxidative damage in frataxin-deficient yeasts are magnesium-binding proteins. Free Radic. Biol. Med. 44, 1712-1723.
-
(2008)
Free Radic. Biol. Med.
, vol.44
, pp. 1712-1723
-
-
Irazusta, V.1
Moreno-Cermeño, A.2
Cabiscol, E.3
Ros, J.4
Tamarit, J.5
-
42
-
-
0034891783
-
Oxidative modification of proteins during aging
-
Levine, R. L. and Stadtman, E. R. (2001) Oxidative modification of proteins during aging. Exp. Gerontol. 36, 1495-1502.
-
(2001)
Exp. Gerontol.
, vol.36
, pp. 1495-1502
-
-
Levine, R.L.1
Stadtman, E.R.2
-
43
-
-
0032903802
-
Oxidative stress in Huntington's disease
-
Browne, S. E., Ferrante, R. J., and Beal, M. F. (1999) Oxidative stress in Huntington's disease. Brain Pathol. 9, 147-163.
-
(1999)
Brain Pathol.
, vol.9
, pp. 147-163
-
-
Browne, S.E.1
Ferrante, R.J.2
Beal, M.F.3
-
44
-
-
79961219601
-
Important role of oxidative stress biomarkers in Huntington's disease
-
Túnez, I., Sánchez-López, F., Agüera, E., Fernández-Bolaños, R., Sánchez, F. M., and Tasset-Cuevas, I. (2011) Important role of oxidative stress biomarkers in Huntington's disease. J. Med. Chem. 54, 5602-5606.
-
(2011)
J. Med. Chem.
, vol.54
, pp. 5602-5606
-
-
Túnez, I.1
Sánchez-López, F.2
Agüera, E.3
Fernández-Bolaños, R.4
Sánchez, F.M.5
Tasset-Cuevas, I.6
-
45
-
-
29244479196
-
Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease
-
Perluigi, M., Poon, H. F., Maragos, W., Pierce, W. M., Klein, J. B., Calabrese, V., Cini, C., De Marco, C., and Butterfield, D. A. (2005) Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Mol. Cell Proteomics 4, 1849-1861.
-
(2005)
Mol. Cell Proteomics
, vol.4
, pp. 1849-1861
-
-
Perluigi, M.1
Poon, H.F.2
Maragos, W.3
Pierce, W.M.4
Klein, J.B.5
Calabrese, V.6
Cini, C.7
De Marco, C.8
Butterfield, D.A.9
-
46
-
-
84889312510
-
-
in Dalle-Donne, I., Scaloni, A., Butterfield, D. A. (Eds.) Wiley, Hoboken, NJ.
-
Cabiscol, E., Ros, J. in Dalle-Donne, I., Scaloni, A., Butterfield, D. A. (Eds.) (2006) Redox Proteomics. From Protein Modifications to Cellular Dysfunction and Diseases. Wiley, Hoboken, NJ. pp. 399-472.
-
(2006)
Redox Proteomics. From Protein Modifications to Cellular Dysfunction and Diseases
, pp. 399-472
-
-
Cabiscol, E.1
Ros, J.2
-
47
-
-
77649215222
-
3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future
-
Túnez, I., Tasset, I., Pérez-De La Cruz, V., and Santamaría, A. (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules 15, 878-916.
-
(2010)
Molecules
, vol.15
, pp. 878-916
-
-
Túnez, I.1
Tasset, I.2
Pérez-De La Cruz, V.3
Santamaría, A.4
-
48
-
-
0034628981
-
3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease
-
La Fontaine, M. A., Geddes, J. W., Banks, A., and Butterfield, D. A. (2000) 3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease. Brain Res. 858, 356-362.
-
(2000)
Brain Res.
, vol.858
, pp. 356-362
-
-
La Fontaine, M.A.1
Geddes, J.W.2
Banks, A.3
Butterfield, D.A.4
-
49
-
-
0027198567
-
Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum
-
Greene, J. G., Porter, R. H., Eller, R. V., and Greenamyre, J. T. (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61, 1151-1154.
-
(1993)
J. Neurochem.
, vol.61
, pp. 1151-1154
-
-
Greene, J.G.1
Porter, R.H.2
Eller, R.V.3
Greenamyre, J.T.4
-
50
-
-
0028017704
-
Creatine kinase in non-muscle tissues and cells
-
Wallimann, T. and Hemmer, W. (1994) Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133-134, 193-220.
-
(1994)
Mol. Cell. Biochem.
, vol.133-134
, pp. 193-220
-
-
Wallimann, T.1
Hemmer, W.2
-
51
-
-
0031712655
-
Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach
-
Schlattner, U., Forstner, M., Eder, M., Stachowiak, O., Fritz-Wolf, K., and Wallimann, T. (1998) Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach. Mol. Cell. Biochem. 184, 125-140.
-
(1998)
Mol. Cell. Biochem.
, vol.184
, pp. 125-140
-
-
Schlattner, U.1
Forstner, M.2
Eder, M.3
Stachowiak, O.4
Fritz-Wolf, K.5
Wallimann, T.6
-
52
-
-
0034660457
-
Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
-
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., and Beal, M. F. (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J. Neurosci. 20, 4389-4397.
-
(2000)
J. Neurosci.
, vol.20
, pp. 4389-4397
-
-
Ferrante, R.J.1
Andreassen, O.A.2
Jenkins, B.G.3
Dedeoglu, A.4
Kuemmerle, S.5
Kubilus, J.K.6
Kaddurah-Daouk, R.7
Hersch, S.M.8
Beal, M.F.9
-
53
-
-
0034743672
-
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease
-
Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., Jenkins, B. G., Ferrante, K. L., Thomas, M., Friedlich, A., Browne, S. E., Schilling, G., Borchelt, D. R., Hersch, S. M., Ross, C. A., and Beal, M. F. (2001) Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiol. Dis. 8, 479-491.
-
(2001)
Neurobiol. Dis.
, vol.8
, pp. 479-491
-
-
Andreassen, O.A.1
Dedeoglu, A.2
Ferrante, R.J.3
Jenkins, B.G.4
Ferrante, K.L.5
Thomas, M.6
Friedlich, A.7
Browne, S.E.8
Schilling, G.9
Borchelt, D.R.10
Hersch, S.M.11
Ross, C.A.12
Beal, M.F.13
-
54
-
-
0141959170
-
Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial
-
Verbessem, P., Lemiere, J., Eijnde, B. O., Swinnen, S., Vanhees, L., Van Leemputte, M., Hespel, P., and Dom, R. (2003) Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial. Neurology. 61, 925-930.
-
(2003)
Neurology.
, vol.61
, pp. 925-930
-
-
Verbessem, P.1
Lemiere, J.2
Eijnde, B.O.3
Swinnen, S.4
Vanhees, L.5
Van Leemputte, M.6
Hespel, P.7
Dom, R.8
-
55
-
-
19944431628
-
Creatine supplementation lowers brain glutamate levels in Huntington's disease
-
Bender, A., Auer, D. P., Merl, T., Reilmann, R., Saemann, P., Yassouridis, A., Bender, J., Weindl, A., Dose, M., Gasser, T., and Klopstock, T. (2005) Creatine supplementation lowers brain glutamate levels in Huntington's disease. J. Neurol. 252, 36-41.
-
(2005)
J. Neurol.
, vol.252
, pp. 36-41
-
-
Bender, A.1
Auer, D.P.2
Merl, T.3
Reilmann, R.4
Saemann, P.5
Yassouridis, A.6
Bender, J.7
Weindl, A.8
Dose, M.9
Gasser, T.10
Klopstock, T.11
-
56
-
-
0029875381
-
Mitochondrial defect in Huntington's disease caudate nucleus
-
Gu, M., Gash, M. T., Mann, V. M., Javoy-Agid, F., Cooper, J. M., and Schapira, A. H. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 385-389.
-
(1996)
Ann. Neurol.
, vol.39
, pp. 385-389
-
-
Gu, M.1
Gash, M.T.2
Mann, V.M.3
Javoy-Agid, F.4
Cooper, J.M.5
Schapira, A.H.6
-
57
-
-
0027741301
-
Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy
-
Jenkins, B. G., Koroshetz, W. J., Beal, M. F., and Rosen, B. R. (1993) Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43, 2689-2695.
-
(1993)
Neurology
, vol.43
, pp. 2689-2695
-
-
Jenkins, B.G.1
Koroshetz, W.J.2
Beal, M.F.3
Rosen, B.R.4
-
58
-
-
71949108518
-
Mitochondria in Huntington's disease
-
Damiano, M., Galvan, L., Déglon, N., and Brouillet, E. (2010) Mitochondria in Huntington's disease. Biochim. Biophys. Acta 1802, 52-61.
-
(2010)
Biochim. Biophys. Acta
, vol.1802
, pp. 52-61
-
-
Damiano, M.1
Galvan, L.2
Déglon, N.3
Brouillet, E.4
-
59
-
-
75949083202
-
Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates
-
Martínez, A., Portero-Otin, M., Pamplona, R., and Ferrer, I. (2010) Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol. 20, 281-297.
-
(2010)
Brain Pathol.
, vol.20
, pp. 281-297
-
-
Martínez, A.1
Portero-Otin, M.2
Pamplona, R.3
Ferrer, I.4
-
60
-
-
9544255791
-
A controlled trial of idebenone in Huntington's disease
-
Ranen, N. G., Peyser, C. E., Coyle, J. T., Bylsma, F. W., Sherr, M., Day, L., Folstein, M. F., Brandt, J., Ross, C. A., and Folstein, S. E. (1996) A controlled trial of idebenone in Huntington's disease. Mov. Disord. 11, 549-554.
-
(1996)
Mov. Disord.
, vol.11
, pp. 549-554
-
-
Ranen, N.G.1
Peyser, C.E.2
Coyle, J.T.3
Bylsma, F.W.4
Sherr, M.5
Day, L.6
Folstein, M.F.7
Brandt, J.8
Ross, C.A.9
Folstein, S.E.10
-
61
-
-
34247390079
-
Polyglutamine-mediated neurodegeneration: use of chaperones as prevention strategy
-
Paul, S. (2007) Polyglutamine-mediated neurodegeneration: use of chaperones as prevention strategy. Biochemistry (Mosc). 72, 359-366.
-
(2007)
Biochemistry (Mosc).
, vol.72
, pp. 359-366
-
-
Paul, S.1
-
62
-
-
67650745109
-
Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease
-
Wacker, J. L., Huang, S. Y., Steele, A. D., Aron, R., Lotz, G. P., Nguyen, Q, Giorgini, F, Roberson, ED, Lindquist, S, Masliah, E, and Muchowski, P. J. (2009) Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease. J. Neurosci. 29, 9104-9114.
-
(2009)
J. Neurosci.
, vol.29
, pp. 9104-9114
-
-
Wacker, J.L.1
Huang, S.Y.2
Steele, A.D.3
Aron, R.4
Lotz, G.P.5
Nguyen, Q.6
Giorgini, F.7
Roberson, E.D.8
Lindquist, S.9
Masliah, E.10
Muchowski, P.J.11
-
63
-
-
70149124059
-
Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment
-
Tantucci, M., Mariucci, G., Taha, E., Spaccatini, C., Tozzi, A., Luchetti, E., Calabresi, P., and Ambrosini, M. V. (2009) Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment. Neuroscience 163, 735-740.
-
(2009)
Neuroscience
, vol.163
, pp. 735-740
-
-
Tantucci, M.1
Mariucci, G.2
Taha, E.3
Spaccatini, C.4
Tozzi, A.5
Luchetti, E.6
Calabresi, P.7
Ambrosini, M.V.8
-
64
-
-
23244452271
-
Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation
-
Novoselova, T. V., Margulis, B. A., Novoselov, S. S., Sapozhnikov, A. M., van der Spuy, J., Cheetham, M. E., and Guzhova, I. V. (2005) Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J. Neurochem. 94, 597-606.
-
(2005)
J. Neurochem.
, vol.94
, pp. 597-606
-
-
Novoselova, T.V.1
Margulis, B.A.2
Novoselov, S.S.3
Sapozhnikov, A.M.4
van der Spuy, J.5
Cheetham, M.E.6
Guzhova, I.V.7
-
65
-
-
33749177252
-
The chaperoninTRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions
-
Tam, S., Séller, R., Spiess, C., and Frydman, J. (2006) The chaperoninTRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat. Cell. Biol. 8, 1155-1162.
-
(2006)
Nat. Cell. Biol.
, vol.8
, pp. 1155-1162
-
-
Tam, S.1
Séller, R.2
Spiess, C.3
Frydman, J.4
-
66
-
-
54449101793
-
Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones
-
Fujikake, N., Nagai, Y., Popiel, H. A., Okamoto, Y., Yamaguchi, M, and Toda, T. (2008) Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J. Biol. Chem. 283, 26188-26197.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 26188-26197
-
-
Fujikake, N.1
Nagai, Y.2
Popiel, H.A.3
Okamoto, Y.4
Yamaguchi, M.5
Toda, T.6
-
67
-
-
75749136948
-
Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease
-
Neef, D. W., Tursi, M. L., and Thiele, D. J. (2010) Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease. PLoS Biol. 8, e1000291.
-
(2010)
PLoS Biol.
, vol.8
-
-
Neef, D.W.1
Tursi, M.L.2
Thiele, D.J.3
-
68
-
-
19444375216
-
Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling
-
Rhee, S. G., Chae, H. Z., and Kim, K. (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38, 1543-1552.
-
(2005)
Free Radic. Biol. Med.
, vol.38
, pp. 1543-1552
-
-
Rhee, S.G.1
Chae, H.Z.2
Kim, K.3
-
69
-
-
1642464018
-
A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells
-
Paron, I., D'Elia, A., D'Ambrosio, C., Scaloni, A., D'Aurizio, F., Prescott, A., Damante, G., and Tell, G. (2004) A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem. J. 378, 929-937.
-
(2004)
Biochem. J.
, vol.378
, pp. 929-937
-
-
Paron, I.1
D'Elia, A.2
D'Ambrosio, C.3
Scaloni, A.4
D'Aurizio, F.5
Prescott, A.6
Damante, G.7
Tell, G.8
-
70
-
-
80054681001
-
Vitamin B(6) salvage enzymes: mechanism, structure and regulation
-
di Salvo, M. L., Contestabile, R., and Safo, M. K. (2011) Vitamin B(6) salvage enzymes: mechanism, structure and regulation. Biochim. Biophys. Acta. 1814, 1597-1608.
-
(2011)
Biochim. Biophys. Acta.
, vol.1814
, pp. 1597-1608
-
-
di Salvo, M.L.1
Contestabile, R.2
Safo, M.K.3
-
71
-
-
20244367772
-
Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox (am)ine 5′-phosphate oxidase
-
Mills, P. B., Surtees, R. A., Champion, M. P., Beesley, C. E., Dalton, N., Scambler, P. J., Heales, S. J., Briddon, A., Scheimberg, I., Hoffmann, G. F., Zschocke, J., and Clayton, P. T. (2005) Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox (am)ine 5′-phosphate oxidase. Hum. Mol. Genet. 14, 1077-1086.
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 1077-1086
-
-
Mills, P.B.1
Surtees, R.A.2
Champion, M.P.3
Beesley, C.E.4
Dalton, N.5
Scambler, P.J.6
Heales, S.J.7
Briddon, A.8
Scheimberg, I.9
Hoffmann, G.F.10
Zschocke, J.11
Clayton, P.T.12
-
72
-
-
33846454698
-
Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy
-
Hoffmann, G. F., Schmitt, B., Windfuhr, M., Wagner, N., Strehl, H., Bagci, S., Franz, A. R., Mills, P. B., Clayton, P. T., Baumgartner, M. R., Steinmann, B., Bast, T., Wolf, N. I., and Zschocke, J. (2007) Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy. J. Inherit. Metab. Dis. 30, 96-99.
-
(2007)
J. Inherit. Metab. Dis.
, vol.30
, pp. 96-99
-
-
Hoffmann, G.F.1
Schmitt, B.2
Windfuhr, M.3
Wagner, N.4
Strehl, H.5
Bagci, S.6
Franz, A.R.7
Mills, P.B.8
Clayton, P.T.9
Baumgartner, M.R.10
Steinmann, B.11
Bast, T.12
Wolf, N.I.13
Zschocke, J.14
-
73
-
-
33644821320
-
Mutations in antiquitin in individuals with pyridoxine-dependent seizures
-
Mills, P.B., Struys, E., Jakobs, C., Plecko, B., Baxter, P., Baumgartner, M., Willemsen, M. A., Omran, H., Tacke, U., Uhlenberg, B., Weschke, B., and Clayton, P. T. (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat. Med. 12, 307-309.
-
(2006)
Nat. Med.
, vol.12
, pp. 307-309
-
-
Mills, P.B.1
Struys, E.2
Jakobs, C.3
Plecko, B.4
Baxter, P.5
Baumgartner, M.6
Willemsen, M.A.7
Omran, H.8
Tacke, U.9
Uhlenberg, B.10
Weschke, B.11
Clayton, P.T.12
-
74
-
-
33947574490
-
Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime
-
Rankin, P. M., Harrison, S., Chong, W. K., Boyd, S., and Aylett, S. E. (2007) Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime. Dev. Med. Child. Neurol. 49, 300-305.
-
(2007)
Dev. Med. Child. Neurol.
, vol.49
, pp. 300-305
-
-
Rankin, P.M.1
Harrison, S.2
Chong, W.K.3
Boyd, S.4
Aylett, S.E.5
-
75
-
-
0015790444
-
Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain
-
Perry, T. L., Hansen, S., and Kloster, M. (1973) Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. N. Engl. J. Med. 288, 337-342.
-
(1973)
N. Engl. J. Med.
, vol.288
, pp. 337-342
-
-
Perry, T.L.1
Hansen, S.2
Kloster, M.3
-
76
-
-
0023258197
-
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain
-
Reynolds, G. P. and Pearson, S. J. (1987) Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain. Neurosci. Lett. 78, 233-238.
-
(1987)
Neurosci. Lett.
, vol.78
, pp. 233-238
-
-
Reynolds, G.P.1
Pearson, S.J.2
-
77
-
-
33644843611
-
Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy
-
Tsang, T. M., Woodman, B., McLoughlin, G. A., Griffin, J. L., Tabrizi, S. J., Bates, G. P., and Holmes, E. (2006) Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. J. Proteome Res. 5, 483-492.
-
(2006)
J. Proteome Res.
, vol.5
, pp. 483-492
-
-
Tsang, T.M.1
Woodman, B.2
McLoughlin, G.A.3
Griffin, J.L.4
Tabrizi, S.J.5
Bates, G.P.6
Holmes, E.7
-
78
-
-
0018164927
-
Long term treatment of Huntington disease with L-glutamate and pyridoxine
-
Barr, A. N., Heinze, W., Mendoza, J. E., and Perlik, S. (1978) Long term treatment of Huntington disease with L-glutamate and pyridoxine. Neurology. 28, 1280-1282.
-
(1978)
Neurology.
, vol.28
, pp. 1280-1282
-
-
Barr, A.N.1
Heinze, W.2
Mendoza, J.E.3
Perlik, S.4
-
79
-
-
0029943742
-
Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory
-
Taylor-Robinson, S. D., Weeks, R. A., Bryant, D. J., Sargentoni, J., Marcus, C. D., Harding, A. E., and Brooks, D. J. (1996) Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory. Mov. Disord. 11, 167-173.
-
(1996)
Mov. Disord.
, vol.11
, pp. 167-173
-
-
Taylor-Robinson, S.D.1
Weeks, R.A.2
Bryant, D.J.3
Sargentoni, J.4
Marcus, C.D.5
Harding, A.E.6
Brooks, D.J.7
-
80
-
-
0033593634
-
Energy on demand
-
Magistretti, P. J., Pellerin, L., Rothman, D. L., and Shulman, R. G. (1999) Energy on demand. Science 283, 496-497.
-
(1999)
Science
, vol.283
, pp. 496-497
-
-
Magistretti, P.J.1
Pellerin, L.2
Rothman, D.L.3
Shulman, R.G.4
-
81
-
-
0026587422
-
The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia
-
Gerfen, C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15, 285-320.
-
(1992)
Annu. Rev. Neurosci.
, vol.15
, pp. 285-320
-
-
Gerfen, C.R.1
-
82
-
-
73949101687
-
Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum
-
Ortiz, A. N., Kurth, B. J., Osterhaus, G. L., and Johnson, M. A. (2010) Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum. J. Neurochem. 112, 755-761.
-
(2010)
J. Neurochem.
, vol.112
, pp. 755-761
-
-
Ortiz, A.N.1
Kurth, B.J.2
Osterhaus, G.L.3
Johnson, M.A.4
-
83
-
-
79953671359
-
Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 mice
-
Mochel, F., Durant, B., Durr, A., and Schiffmann, R. (2011) Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 mice. PLoS One. 6, e18336.
-
(2011)
PLoS One.
, vol.6
-
-
Mochel, F.1
Durant, B.2
Durr, A.3
Schiffmann, R.4
-
84
-
-
57049139342
-
A Europe-wide assessment of current medication choices in Huntington's disease
-
Priller, J., Ecker, D., Landwehrmeyer, B., and Craufurd, D. (2008) A Europe-wide assessment of current medication choices in Huntington's disease. Mov. Disord. 23, 1788.
-
(2008)
Mov. Disord.
, vol.23
, pp. 1788
-
-
Priller, J.1
Ecker, D.2
Landwehrmeyer, B.3
Craufurd, D.4
-
85
-
-
33745759912
-
Pharmacological management of Huntington's disease: an evidence-based review
-
Bonelli, R. M. and Wenning, G. K. (2006) Pharmacological management of Huntington's disease: an evidence-based review. Curr. Pharm. Des. 12, 2701-2720.
-
(2006)
Curr. Pharm. Des.
, vol.12
, pp. 2701-2720
-
-
Bonelli, R.M.1
Wenning, G.K.2
-
86
-
-
37749000434
-
Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study
-
Klepac, N., Relja, M., Klepac, R., Hećimović, S., Babić, T., and Trkulja, V. (2007) Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study. J. Neurol. 254, 1676-1683.
-
(2007)
J. Neurol.
, vol.254
, pp. 1676-1683
-
-
Klepac, N.1
Relja, M.2
Klepac, R.3
Hećimović, S.4
Babić, T.5
Trkulja, V.6
-
87
-
-
0018871589
-
Metabolic impairment and membrane abnormality in red cells from Huntington's disease
-
Zanella, A., Izzo, C., Meola, G., Mariani, M., Colotti, M. T., Silani, V., Pellegata, G., and Scarlato, G. (1980) Metabolic impairment and membrane abnormality in red cells from Huntington's disease. J. Neurol. Sci. 47, 93-103.
-
(1980)
J. Neurol. Sci.
, vol.47
, pp. 93-103
-
-
Zanella, A.1
Izzo, C.2
Meola, G.3
Mariani, M.4
Colotti, M.T.5
Silani, V.6
Pellegata, G.7
Scarlato, G.8
-
88
-
-
22544469454
-
Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model
-
Choo, Y. S., Mao, Z., Johnson, G. V., and Lesort, M. (2005) Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model. Neurosci. Lett. 386, 63-68.
-
(2005)
Neurosci. Lett.
, vol.386
, pp. 63-68
-
-
Choo, Y.S.1
Mao, Z.2
Johnson, G.V.3
Lesort, M.4
-
89
-
-
78649277278
-
Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease
-
Thevandavakkam, M. A., Schwarcz, R., Muchowski, P. J., and Giorgini, F. (2010) Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease. CNS Neurol. Disord. Drug Targets 9, 791-800.
-
(2010)
CNS Neurol. Disord. Drug Targets
, vol.9
, pp. 791-800
-
-
Thevandavakkam, M.A.1
Schwarcz, R.2
Muchowski, P.J.3
Giorgini, F.4
-
90
-
-
18144386929
-
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
-
Stoy, N., Mackay, G. M., Forrest, C. M., Christofides, J., Egerton, M., Stone, T. W., and Darlington, L. G. (2005) Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J. Neurochem. 93, 611-623.
-
(2005)
J. Neurochem.
, vol.93
, pp. 611-623
-
-
Stoy, N.1
Mackay, G.M.2
Forrest, C.M.3
Christofides, J.4
Egerton, M.5
Stone, T.W.6
Darlington, L.G.7
-
91
-
-
0025161567
-
Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid
-
Beal, M. F., Matson, W. R., Swartz, K. J., Gamache, P. H., and Bird, E. D. (1990) Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J. Neurochem. 55, 1327-1239.
-
(1990)
J. Neurochem.
, vol.55
, pp. 1327-1239
-
-
Beal, M.F.1
Matson, W.R.2
Swartz, K.J.3
Gamache, P.H.4
Bird, E.D.5
-
92
-
-
0028903541
-
Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases
-
Jauch, D., Urbańska, E. M., Guidetti, P., Bird, E. D., Vonsattel, J. P., Whetsell, W. O. Jr., and Schwarcz, R. (1995) Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases. J. Neurol Sci. 130, 39-47.
-
(1995)
J. Neurol Sci.
, vol.130
, pp. 39-47
-
-
Jauch, D.1
Urbańska, E.M.2
Guidetti, P.3
Bird, E.D.4
Vonsattel, J.P.5
Whetsell Jr, W.O.6
Schwarcz, R.7
-
93
-
-
0026783169
-
Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease
-
Pearson, S. J. and Reynolds, G. P. (1992) Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease. Neurosci. Lett. 144, 199-201.
-
(1992)
Neurosci. Lett.
, vol.144
, pp. 199-201
-
-
Pearson, S.J.1
Reynolds, G.P.2
-
94
-
-
76849100874
-
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
-
Schwarcz, R., Guidetti, P., Sathyasaikumar, K. V., and Muchowski, P. J. (2010) Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog. Neurobiol. 90, 230-245.
-
(2010)
Prog. Neurobiol.
, vol.90
, pp. 230-245
-
-
Schwarcz, R.1
Guidetti, P.2
Sathyasaikumar, K.V.3
Muchowski, P.J.4
-
95
-
-
0026043565
-
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
-
Beal, M. F., Ferrante, R. J., Swartz, K. J, and Kowall, N. W. (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11, 1649-1659.
-
(1991)
J. Neurosci.
, vol.11
, pp. 1649-1659
-
-
Beal, M.F.1
Ferrante, R.J.2
Swartz, K.J.3
Kowall, N.W.4
-
96
-
-
34548363867
-
L-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: involvement of src family kinases
-
Mallozzi, C., Martire, A., Domenici, M. R., Metere, A., Popoli, P., and Di Stasi, A. M. (2007) L-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: involvement of src family kinases. J. Neurosci. Res. 85, 2770-2777.
-
(2007)
J. Neurosci. Res.
, vol.85
, pp. 2770-2777
-
-
Mallozzi, C.1
Martire, A.2
Domenici, M.R.3
Metere, A.4
Popoli, P.5
Di Stasi, A.M.6
-
97
-
-
79958021894
-
Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration
-
Zwilling, D., Huang, S. Y., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H. Q., Lee, J., Truong, J., Andrews-Zwilling, Y., Hsieh, E. W., et el. (2011) Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell. 145, 863-874.
-
(2011)
Cell.
, vol.145
, pp. 863-874
-
-
Zwilling, D.1
Huang, S.Y.2
Sathyasaikumar, K.V.3
Notarangelo, F.M.4
Guidetti, P.5
Wu, H.Q.6
Lee, J.7
Truong, J.8
Andrews-Zwilling, Y.9
Hsieh, E.W.10
-
98
-
-
32644481227
-
Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction
-
Goswami, A., Dikshit, P., Mishra, A., Mulherkar, S., Nukina, N., and Jana, N. R. (2006) Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. Biochem. Biophys. Res. Commun. 342, 184-190.
-
(2006)
Biochem. Biophys. Res. Commun.
, vol.342
, pp. 184-190
-
-
Goswami, A.1
Dikshit, P.2
Mishra, A.3
Mulherkar, S.4
Nukina, N.5
Jana, N.R.6
-
99
-
-
55349106939
-
Mechanisms of copper ion mediated Huntington's disease progression
-
Fox, J. H., Kama, J. A., Lieberman, G., Chopra, R., Dorsey, K., Chopra, V., Volitakis, I., Cherny, R. A., Bush, A. I., and Hersch, S. (2007) Mechanisms of copper ion mediated Huntington's disease progression. PLoS One 2, e334.
-
(2007)
PLoS One
, vol.2
-
-
Fox, J.H.1
Kama, J.A.2
Lieberman, G.3
Chopra, R.4
Dorsey, K.5
Chopra, V.6
Volitakis, I.7
Cherny, R.A.8
Bush, A.I.9
Hersch, S.10
-
100
-
-
0037461730
-
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
-
Sánchez, I., Mahlke, C., and Yuan, J. (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373-379.
-
(2003)
Nature
, vol.421
, pp. 373-379
-
-
Sánchez, I.1
Mahlke, C.2
Yuan, J.3
-
101
-
-
7244236320
-
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
-
Arrasate, M., Mitra, S., Schweitze, r E. S., Segal, M. R., and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810.
-
(2004)
Nature
, vol.431
, pp. 805-810
-
-
Arrasate, M.1
Mitra, S.2
Schweitze, R.E.S.3
Segal, M.R.4
Finkbeiner, S.5
-
102
-
-
49149124343
-
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
-
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., Regan, C. M., Walsh, D. M., Sabatini, B. L., and Selkoe, D. J. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842.
-
(2008)
Nat. Med.
, vol.14
, pp. 837-842
-
-
Shankar, G.M.1
Li, S.2
Mehta, T.H.3
Garcia-Munoz, A.4
Shepardson, N.E.5
Smith, I.6
Brett, F.M.7
Farrell, M.A.8
Rowan, M.J.9
Lemere, C.A.10
Regan, C.M.11
Walsh, D.M.12
Sabatini, B.L.13
Selkoe, D.J.14
-
103
-
-
33748685003
-
Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease
-
Muntané, G., Dalfó, E., Martínez, A., Rey, M. J., Avila, J., Pérez, M., Portero, M., Pamplona, R., Ayala, V., and Ferrer, I. (2006) Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. J. Neurochem. 99, 177-185.
-
(2006)
J. Neurochem.
, vol.99
, pp. 177-185
-
-
Muntané, G.1
Dalfó, E.2
Martínez, A.3
Rey, M.J.4
Avila, J.5
Pérez, M.6
Portero, M.7
Pamplona, R.8
Ayala, V.9
Ferrer, I.10
-
104
-
-
27744553322
-
Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain
-
Korolainen, M. A., Auriola, S., Nyman, T. A., Alafuzoff, I., and Pirttilä, T. (2005) Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain. Neurobiol. Dis. 20, 858-870.
-
(2005)
Neurobiol. Dis.
, vol.20
, pp. 858-870
-
-
Korolainen, M.A.1
Auriola, S.2
Nyman, T.A.3
Alafuzoff, I.4
Pirttilä, T.5
-
105
-
-
0036522005
-
Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain
-
Kaneko, K., Nakamura, A., Yoshida, K., Kametani, F., Higuchi, K., and Ikeda, S. (2002) Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic. Res. 36, 303-306.
-
(2002)
Free Radic. Res.
, vol.36
, pp. 303-306
-
-
Kaneko, K.1
Nakamura, A.2
Yoshida, K.3
Kametani, F.4
Higuchi, K.5
Ikeda, S.6
-
106
-
-
74049124412
-
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
-
Ju, J. S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., and Weihl, C. C. (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell. Biol. 187, 875-888.
-
(2009)
J. Cell. Biol.
, vol.187
, pp. 875-888
-
-
Ju, J.S.1
Fuentealba, R.A.2
Miller, S.E.3
Jackson, E.4
Piwnica-Worms, D.5
Baloh, R.H.6
Weihl, C.C.7
-
107
-
-
0034772572
-
VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration
-
Hirabayashi, M., Inoue, K., Tanaka, K., Nakadate, K., Ohsawa, Y., Kamei, Y., Popiel, A. H., Sinohara, A., Iwamatsu, A., Kimura, Y., Uchiyama, Y., Hori, S., and Kakizuka, A. (2001) VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell. Death Differ. 8, 977-984.
-
(2001)
Cell. Death Differ.
, vol.8
, pp. 977-984
-
-
Hirabayashi, M.1
Inoue, K.2
Tanaka, K.3
Nakadate, K.4
Ohsawa, Y.5
Kamei, Y.6
Popiel, A.H.7
Sinohara, A.8
Iwamatsu, A.9
Kimura, Y.10
Uchiyama, Y.11
Hori, S.12
Kakizuka, A.13
-
108
-
-
58149398638
-
Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease
-
Schwab, C., Arai, T., Hasegawa, M., Yu, S., and McGeer, P. L. (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J. Neuropathol. Exp. Neurol. 67, 1159-1165.
-
(2008)
J. Neuropathol. Exp. Neurol.
, vol.67
, pp. 1159-1165
-
-
Schwab, C.1
Arai, T.2
Hasegawa, M.3
Yu, S.4
McGeer, P.L.5
-
109
-
-
29244457567
-
ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif
-
Noguchi, M., Takata, T., Kimura, Y., Manno, A., Murakami, K., Koike, M., Ohizumi, H., Hori, S., and Kakizuka, A. (2005) ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif. J. Biol. Chem. 280, 41332-41341.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 41332-41341
-
-
Noguchi, M.1
Takata, T.2
Kimura, Y.3
Manno, A.4
Murakami, K.5
Koike, M.6
Ohizumi, H.7
Hori, S.8
Kakizuka, A.9
-
110
-
-
46549083159
-
Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease
-
Braun, R. J. and Zischka, H. (2008) Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochim. Biophys. Acta. 1783, 1418-1435.
-
(2008)
Biochim. Biophys. Acta.
, vol.1783
, pp. 1418-1435
-
-
Braun, R.J.1
Zischka, H.2
-
111
-
-
36849001753
-
Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia
-
Hong, L. and Fast, W. (2007) Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia. J. Biol. Chem. 282, 34684-34692.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 34684-34692
-
-
Hong, L.1
Fast, W.2
-
112
-
-
0035923560
-
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine
-
Stühlinger, M. C., Tsao, P. S., Her, J. H., Kimoto, M., Balint, R. F., and Cooke, J. P. (2001) Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104, 2569-2575.
-
(2001)
Circulation
, vol.104
, pp. 2569-2575
-
-
Stühlinger, M.C.1
Tsao, P.S.2
Her, J.H.3
Kimoto, M.4
Balint, R.F.5
Cooke, J.P.6
-
113
-
-
38949090380
-
Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation
-
Forbes, S. P., Druhan, L. J., Guzman, J. E., Parinandi, N., Zhang, L., Green-Church, K. B., and Cardounel, A. J. (2008) Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation. Biochemistry 47, 1819-1826.
-
(2008)
Biochemistry
, vol.47
, pp. 1819-1826
-
-
Forbes, S.P.1
Druhan, L.J.2
Guzman, J.E.3
Parinandi, N.4
Zhang, L.5
Green-Church, K.B.6
Cardounel, A.J.7
-
114
-
-
0037183717
-
Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation
-
J. (2002) Age-dependent changes in nitric oxide synthase activity and protein expression in
-
Pérez-Severiano, F., Escalante, B., Vergara, P., Ríos, C., and Segovia, J. (2002) Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation. Brain Res. 951, 36-42.
-
(2002)
Brain Res.
, vol.951
, pp. 36-42
-
-
Pérez-Severiano, F.1
Escalante, B.2
Vergara, P.3
Ríos, C.4
Segovia, J.5
-
116
-
-
0036327065
-
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
-
Panov, A. V., Gutekunst, C. A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., and Greenamyre, J. T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731-736.
-
(2002)
Nat. Neurosci.
, vol.5
, pp. 731-736
-
-
Panov, A.V.1
Gutekunst, C.A.2
Leavitt, B.R.3
Hayden, M.R.4
Burke, J.R.5
Strittmatter, W.J.6
Greenamyre, J.T.7
-
117
-
-
0034597411
-
Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity
-
Leventhal, L., Sortwell, C. E., Hanbury, R., Collier, T. J., Kordower, J. H., and Palfi, S. (2000) Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. J. Comp. Neurol. 425, 471-478.
-
(2000)
J. Comp. Neurol.
, vol.425
, pp. 471-478
-
-
Leventhal, L.1
Sortwell, C.E.2
Hanbury, R.3
Collier, T.J.4
Kordower, J.H.5
Palfi, S.6
-
118
-
-
0030296755
-
Mitochondrial ATP synthase: Fe2+-catalyzed fragmentation of the soluble F1-ATPase
-
Belogrudov, G. I. (1996) Mitochondrial ATP synthase: Fe2+-catalyzed fragmentation of the soluble F1-ATPase. Arch. Biochem. Biophys. 335, 131-138.
-
(1996)
Arch. Biochem. Biophys.
, vol.335
, pp. 131-138
-
-
Belogrudov, G.I.1
-
119
-
-
0031046388
-
Differential inactivation of alcohol dehydrogenase isoenzymes in Zymomonas mobilis by oxygen
-
Tamarit, J., Cabiscol, E., Aguilar, J., and Ros, J. (1997) Differential inactivation of alcohol dehydrogenase isoenzymes in Zymomonas mobilis by oxygen. J. Bacteriol. 179, 1102-1104.
-
(1997)
J. Bacteriol.
, vol.179
, pp. 1102-1104
-
-
Tamarit, J.1
Cabiscol, E.2
Aguilar, J.3
Ros, J.4
-
120
-
-
0027482738
-
Reactive species and their accumulation on radical-damaged proteins
-
Dean, R. T., Gieseg, S., and Davies, M. J. (1993) Reactive species and their accumulation on radical-damaged proteins. Trends Biochem. Sci. 18, 437-441.
-
(1993)
Trends Biochem. Sci.
, vol.18
, pp. 437-441
-
-
Dean, R.T.1
Gieseg, S.2
Davies, M.J.3
-
121
-
-
0027480753
-
Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction
-
Uchida, K. and Stadtman, E. R. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J. Biol. Chem. 268, 6388-6393.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 6388-6393
-
-
Uchida, K.1
Stadtman, E.R.2
|